How much does cycloserine cost? What is the difference between the Indian version and the domestic version?

Cycloserine is an anti-tuberculosis drug mainly used to treat drug-resistant Mycobacterium tuberculosis infection. It has been launched in China and has been included in Class B medical insurance, allowing patients to receive treatment at a more favorable price. The common specification of cycloserine is 250mg*10 tablets. The price paid by medical insurance is usually relatively cheap, usually around a few hundred yuan. The specific price may vary due to medical insurance policies and regional differences. Due to reimbursement by medical insurance, the cost borne by patients is relatively low, so cycloserine has become an important drug choice for domestic tuberculosis patients.

In addition to domestically produced cycloserine, generic cycloserine produced in India is also sold in the international market. The common specification of the Indian version of cycloserine is 250mg*60 tablets per box, and the price is about more than 400 yuan. Due to factors such as production costs, transportation and tariffs, the price of Indian versions of drugs is usually higher than that of domestic original drugs. However, compared with original drugs in other European and American countries, the prices of Indian generic drugs are still relatively affordable. If patients choose the Indian version of the drug, they usually face higher initial costs, but the drug's efficacy and ingredients are basically the same as the domestic version and comply with international drug standards.

The ingredients of the domestic version of cycloserine and the Indian generic version are basically the same. Both are cycloserine, the active ingredient, and there is no significant difference in therapeutic effect. Domestic drugs are marketed in the country and undergo strict drug quality supervision to ensure the efficacy and safety of the drugs. Indian generic drugs have also passed relevant certifications and comply with international production standards for drugs. The use effects and clinical applications of both can meet the treatment standards. The main difference lies in the price and manufacturer.
Overall, the price of cycloserine in China is relatively cheap, and after being included in medical insurance, patients can enjoy more favorable treatment costs. Although Indian generic drugs are slightly more expensive, they still provide a relatively economical option, especially for some patients who are not covered by domestic medical insurance. Regardless of whether they choose domestic drugs or Indian versions, patients can make a choice based on their own financial situation and treatment needs, and use the drugs rationally under the guidance of a doctor.
Reference: https://en.wikipedia.org/wiki/Cycloserine